Picture of VivoSim Labs logo

VIVS — VivoSim Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company

Feb 25 (Reuters) - Eli Lilly and Co LLY.N:

ORGANOVO’S FXR PROGRAM, INCLUDING FXR314, TO BE ACQUIRED BY ELI LILLY AND COMPANY

ORGANOVO HOLDINGS INC - TO RECEIVE UPFRONT PAYMENT AND MILESTONES FOR FXR314

ORGANOVO HOLDINGS INC - LILLY ACQUIRES ALL COMMERCIAL AND IP RIGHTS TO FXR PROGRAM

Source text: ID:nGNX2v9LqC

Further company coverage: LLY.N

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on VivoSim Labs

See all news